Kodak names Jackman CTO

Article

Michael W. Jackman has been named chief technology officer and a divisional vice president for Kodak's Health Imaging Group. He will lead Health Imaging's global R&D operation with a strategic focus on delivering new technology, products, and services by

Michael W. Jackman has been named chief technology officer and a divisional vice president for Kodak's Health Imaging Group. He will lead Health Imaging's global R&D operation with a strategic focus on delivering new technology, products, and services by leveraging intellectual property and technology investments, according to the company. Jackman will also steer the design, development, and expansion of Health Imaging's digital product portfolio. Jackman was founder and CEO of a consulting firm specializing in technology development and strategy for companies in the wireless, IP telephony, security, and software infrastructure areas. He has held top marketing, sales, and development positions at various technology companies including IBM. Health Imaging is Kodak's second-largest business, with annual revenue of more than $2.3 billion.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.